Inducible tissue constructs and uses thereof
US-2024287463-A1 · Aug 29, 2024 · US
US9758766B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9758766-B2 |
| Application number | US-201414565104-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 9, 2014 |
| Priority date | Jul 2, 2008 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides an artificial kidney precursor containing a non-human mammalian metanephros separated out from a living body, wherein the metanephros has been subjected to freezing and thawing treatments outside a living body, and contains mammalian mesenchymal stem cells transferred outside a living body, and a method of production thereof.
Opening claim text (preview).
What is claimed is: 1. A method of producing an artificial kidney precursor that is to be transplanted to a human recipient, the precursor comprising: a non-human mammalian metanephros comprising blast cells of a kidney; and human mesenchymal stem cells isolated from the human recipient, which method comprises the steps of: (I) freezing the non-human mammalian metanephros comprising blast cells of a kidney, said metanephros being separated out from a non-human mammalian embryo outside the living body; (II) thawing the frozen mammalian metanephros; and (III) transferring said human mesenchymal stem cells into the metanephros comprising blast cells of a kidney, outside the living body of the non-human mammalian embryo after the thawing (II), thereby obtaining the artificial kidney precursor. 2. The method according to claim 1 , wherein the metanephros used in (I) is a metanephros separated out from a non-human mammalian embryo in a stage where the expression of WIC is still immature. 3. The method according to claim 1 , wherein the artificial kidney precursor is capable of acquiring a potential for erythropoietin production when transplanted into an omentum of the human recipient. 4. The method according to claim 1 , further comprising transplanting the obtained artificial kidney precursor into the human recipient.
embryonic cells · CPC title
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00) · CPC title
Kidney cells · CPC title
from mesenchymal stem cells · CPC title
Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.